Developer of LaryngoStop solution designed to secure the ETI
method by minimizing risks of asphyxia and death.
Overview
The Company was founded in June 2004 in order to decide problems
Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
of Endo Tracheal Intubation (ETI), commonly used in
anesthesiology and emergency medicine by paramedics, physicians
in ERs and IC units, military physicians, paramedics and other
skilled emergency care providers.
ETI is one of the most common medical procedures in the world.
ETI uses direct laryngoscopy as the primary method. During this
procedure a rigid laryngoscope is inserted through the patient's
mouth into the upper airway to control the airflow.
In spite of the fact that ETI has been introduced more than 30
years ago and has been extensively used, this procedure is still
recognized as uniquely difficult.
LaryngoStop solution is based on the deep understanding of the
unmet clinical need in the most important field of medical care -
life saving.
LaryngoStop is designed to secure the ETI method by minimizing
risksof asphyxia and death.
LaryngoStop is a highly effective solution that is most
beneficial for the patients and highly usable for the medical
care providers.
The Company's mission is to advance the most common and essential
life saving method of Endo Tracheal Intubation and to allow
emergency care providers and curers to save more lives in a more
efficient and secured way.
The Company's vision is to become the leader in the market of
time-controlled laryngoscopy devices capitalizing on current
method pitfalls.
